Remifentanil inferior to neuromuscular blockers for successful tracheal intubation in adults at risk of aspiration

Written By :  Aditi
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2023-02-22 00:45 GMT   |   Update On 2023-02-22 00:45 GMT
Advertisement

France: An original investigation published in JAMA has concluded that Remifentanil was statistically inferior to neuromuscular blockers in adults at risk of aspiration during rapid sequence intubation.

There remains uncertainty on whether a rapid-onset opioid is non-inferior to a rapid-onset neuromuscular blocker during rapid sequence intubation?

Grillot et al. and colleagues from Nantes Université and 2Université Lille, France, did a study with the main objective of determining, "Are rapid-onset opioids non-inferior to rapid-onset neuromuscular blockers for rapid sequence intubation?"

Advertisement

The study summary includes the following:

  • The study was carried out in 15 hospitals in France. There were a total of 1150 randomized patients with a mean age of 51 years.
  • Patients were randomized as:

Five hundred seventy-five patients received intravenous Remifentanil 3 to 4 μg/kg immediately after injection of a hypnotic.

Five hundred seventy-five patients received neuromuscular blockers, intravenous succinylcholine or rocuronium 1 mg/kg immediately after injection of a hypnotic.

  • The researchers measured the primary outcome as successful tracheal intubation without major complications (in the first attempt).
  • The successful intubation on the first attempt occurred in 374 out of 575 patients, constituting 66.1 % receiving Remifentanil.
  • Among patients receiving Neuromuscular blockers, 408 out of 575 patients constituting 71.6 %, had successful intubation on the first attempt.
  • Remifentanil was inferior to neuromuscular blockers. The adjusted between-group difference was –6.1%.
  • Nineteen patients with Remifentanil and 3 with neuromuscular blockers had hemodynamic instability with an adjusted difference of 2.8%.

To conclude, as per the study's findings, Remifentanil was inferior to neuromuscular blockers in the rate of successful tracheal intubation without major complications.

Further reading:

Grillot N et al. Effect of Remifentanil vs Neuromuscular Blockers During Rapid Sequence Intubation on Successful Intubation Without Major Complications Among Patients at Risk of Aspiration: A Randomized Clinical Trial. JAMA. 2023;329(1):28–38. doi:10.1001/jama.2022.23550

Tags:    
Article Source : JAMA

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News